Market Access Insights is your compass for navigating the complex oncology landscape. We deliver actionable, data-driven insights that empower biopharmaceutical innovators to optimize market access strategies and drive patient-centric success. Our expertise in oncology market access, healthcare management, and risk management ensures that our clients are equipped with the knowledge needed to thrive in a rapidly evolving industry. HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.
External link for HMP Market Access Insights
Palo Alto, California 94303, US
We want to hear from you! As healthcare policy continues to evolve, which issue do you think is most critical? Vote in the poll and join the conversation! If you haven’t already, check out the latest #BehindtheBill from Katie Hayes, MJ. It’s a must-read on why you should be paying attention to these potential policy shifts. https://lnkd.in/e3FScmBE #HMPMarketAccessInsights #HealthCarePolicy #ExecutiveOrders
This content isn’t available here
Access this content and more in the LinkedIn app
It's Wednesday, which means #BehindtheBill is back! Katie Hayes, MJ explores how Trump’s executive orders, agency leadership changes, and post-Chevron legal standards could reshape health care as we know it. Check it out now! #HMPMarketAccessInsights #BehindtheBill #HealthcarePolicy #ExecutiveOrders
CAR-T and bispecific antibody therapies are transforming cancer care, but access remains limited. In our new Special Topic Report, we explore options that community oncology practices have to help patients take advantage of these innovations. 🔗 https://lnkd.in/eyR3hZa6 We provide key insights into the: ✅ Viability of CAR-T and BsAb therapies in community settings ✅ Key barriers to adoption ✅ Strategic opportunities to expand access Discover key oncology trends, processes, and patterns to improve your market access strategy and improve patient care. 📩 Contact Ramon Auciello to learn how you can access the full report. #HMPMarketAccessInsights #CommunityOncology #NewReport #SpecialTopicReport #CAR_TCellTherapy #BispecificAntibodies #MarketAccess
HMP Market Access Insights reposted this
Happy New Year! As we welcome 2025, we are committed to providing the most up-to-date and impactful programs to help healthcare providers enhance their skills and knowledge. We believe in the power of collaboration, and we are honored to partner with you to advance care and outcomes for patients. To view our full portfolio and register for upcoming events, visit: https://okt.to/CBZMvh #HappyNewYear #NewYear2025 #HealthcareMadePractical
#ICYMI: Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage. Contact Ramon Auciello today to access the report. #HMPMarketAccessInsights #ClinicalPathways #NewReport #OncologyPathways
Katie Hayes, MJ breaks down the shift from legislative wins to implementation challenges between the 117th and 118th Congress. Don’t miss how these shifts could affect you heading into 2025. 👉 Subscribe to the Oncology Access Navigator newsletter to get all the latest Behind the Bill editions and more! #HMPBehindtheBill #BehindtheBill #HMPMarketAccessInsights #MarketAccess #
Warm wishes for the holiday season from the whole team at Market Access Insights! As we gear up for a new year of oncology innovation, we'd like to extend our heartfelt thanks to everyone – our amazing partners, clients, and innovative minds – who was part of our journey this year.🌟 We have some exciting changes coming in 2025 and we cannot wait to bring you along as we continue to navigate the ever-evolving market access landscape. Until then, may your festive season be filled with happiness, appreciation, and memorable moments. ❄️ Happy Holidays! Lee Blansett, Emma Bijesse, Cindy Chen, Daniel Buchenberger, MS, Chris Van Denburg, and Ashutosh K. Sheth #HolidaySeason #Gratitude #MarketAccess #PharmaInsights #2025Outlook
New report alert! 🚨 The 2024-2025 Oncology Clinical Pathways Impact Report is now available on the client portal. Dive deep into the impact of pathways on oncologist's behavior and your brand's market access. Get in touch with Ramon Auciello today to make sure you have access. #HMPMarketAccessInsights #ClinicalPathways #OncologyPathways #Oncology #Research #Healthcareinnovation
Have you read Daniel Buchenberger, MS recent insights article? Check it out now and join the conversation about redefining meaningful metrics for oncology pathways. #HMPMarketAccessInsights #OncologyInsights #ClinicalPathways #HealthcareMetrics #OncologyCare
🌟New Insights🌟 Cindy Chen provides a sneak peek of key insights from the 2024-2025 Oncology Clinical Pathways Impact Report. Check out the her latest post to better understand the variability in pathway integration and usage. Read it now: https://lnkd.in/eaie9CS8 #HMPMarketAccessInsights #OncologyPathways #MarketAccess #ClincialPathways #PathwaysReport